Lutein and Zeaxanthin: Benefits, Forms, Dosing, and Side Effects

Lutein and zeaxanthin are xanthophyll carotenoid pigments — a subclass of the carotenoid family that also includes beta-carotene and lycopene. These compounds are the only carotenoids found in high concentration in the macula of the eye, where they act as natural blue-light filters and antioxidants. Age-related macular degeneration (AMD) is the leading cause of blindness in the United States, affecting more than 9% of people over age 40 and 27% of adults aged 65 and older. Population studies consistently show that people who consume more lutein and zeaxanthin have lower rates of AMD, yet most Americans consume only 1-4 mg per day — well below the 6-10 mg associated with benefit. This comprehensive guide covers the evidence for lutein and zeaxanthin in eye health, cognitive function, skin protection, and more, along with forms, dosing, safety, and dietary sources.

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Lutein and zeaxanthin are xanthophyll carotenoid pigments — a subclass of the carotenoid family that also includes beta-carotene and lycopene. Lutein and zeaxanthin share the same molecular formula (C40H56O2) and are structural isomers: lutein has one beta-ionone ring and one epsilon-ionone ring, while zeaxanthin has two beta-ionone rings, differing in the position of a single double bond [1][2]. A third related compound, meso-zeaxanthin, is a stereoisomer of zeaxanthin that is synthesized locally in the retina from lutein rather than obtained directly from the diet [1][2].

These three carotenoids are the only ones found in high concentration in the macula of the eye — the central region of the retina responsible for fine, detailed color vision. Their collective presence gives the macula its characteristic yellow color (the "macula lutea" or "yellow spot"). Lutein predominates in the peripheral macula, zeaxanthin dominates centrally in the fovea, and meso-zeaxanthin concentrates at the very center [2][3]. Together, they function as a natural blue-light filter (absorbing high-energy wavelengths between 400-500 nm, peaking at approximately 460 nm) and as antioxidants that scavenge free radicals and quench singlet oxygen, protecting the photoreceptors from oxidative damage [2][3][4].

Lutein and zeaxanthin are not synthesized by the human body and must be obtained from the diet or supplements. They are selectively taken up from the bloodstream into the retina through a process mediated by the HDL cholesterol receptor SR-BI located on retinal pigment epithelium cells, which preferentially favors these hydrophilic xanthophylls over other carotenoids like beta-carotene [3][4]. In green vegetables, fruits, and egg yolks, lutein and zeaxanthin exist in the free (unesterified) form, while in marigold flowers (the primary extraction source for supplements), they are naturally present as lutein esters [1][5].

Age-related macular degeneration (AMD) is the leading cause of blindness in the United States. More than 9% of Americans over age 40 show some form of macular degeneration, and the condition affects 27% of adults aged 65 and older [1]. Population studies consistently show that people who consume the most lutein and zeaxanthin from their diets have lower rates of AMD [1]. However, the average American adult consumes only 1-4 mg per day of these carotenoids — well below the 6 mg per day associated with reduced risk in epidemiological studies, and far below the 10-12 mg per day used in clinical supplementation trials [1][2][6].

Lutein and zeaxanthin are also found in smaller amounts in the brain, the skin, and the lens of the eye, where they may play protective roles against oxidative stress. Preliminary evidence suggests potential benefits for cognitive function, skin photoprotection, and cataract prevention, though these non-ocular effects remain less established than the evidence for macular health [2][7].

Forms and Bioavailability

Free Lutein vs. Lutein Esters

Lutein in supplements is available in two primary chemical forms:

• Free (unesterified) lutein — the form found naturally in green vegetables, fruits, and egg yolks. The hydroxyl groups on lutein's ring structures are not bound to fatty acids. Trademarked free-form products include FloraGLO (a starch-based beadlet formula by Kemin Industries) and Lyc-O-Lutein (an alginate-based beadlet formula) [1][5].
• Lutein esters — the form found naturally in marigold (Tagetes erecta) flowers, where the hydroxyl groups are esterified with fatty acids (commonly palmitic or myristic acid). Lutein esters require enzymatic hydrolysis in the small intestine to convert to free lutein before absorption. Trademarked ester products include XANGOLD [1][5].
• Mixed forms — some products like Lutemax (by OmniActive Health Technologies) contain combinations of both free and esterified lutein along with zeaxanthin isomers [1].

The debate over which form is better absorbed has produced mixed results:

• A two-month randomized crossover study comparing 6 mg/day of free lutein (FloraGLO 10%) versus lutein esters (XANGOLD) found both forms to be equally effective at raising blood levels of lutein in younger and older adults [5][8].
• One study reported a 61.6% higher area under the serum concentration-time curve (AUC) for lutein diesters compared to free lutein, suggesting the ester form may have superior bioavailability in some conditions. The researchers concluded that formulation dissolution, rather than ester hydrolysis, is the rate-limiting step [9].
• However, a bioavailability study comparing FloraGLO (starch-based beadlet) versus Lyc-O-Lutein (alginate-based beadlet) — both free-form products — found that lutein levels were more than twice as high with FloraGLO when taken before breakfast. This demonstrates that the delivery matrix matters as much as the chemical form [1][10].

Practical conclusion: Both free and ester forms appear to be effective at raising blood lutein levels. The formulation matrix (beadlet type, oil carrier, softgel composition) may have as much impact on bioavailability as the chemical form itself.

Zeaxanthin: Natural vs. Synthetic

Most zeaxanthin in supplements is derived from plant sources, but a synthetic form has become available in recent years. The European Food Safety Authority (EFSA) evaluated synthetic zeaxanthin and concluded it is safe at daily doses up to 53 mg [1][11].

Meso-Zeaxanthin

Meso-zeaxanthin is produced in the retina from lutein and is also available as a supplement ingredient. Products containing meso-zeaxanthin (such as Macushield and MacuHealth) provide all three macular carotenoids. A three-year clinical trial found that formulas containing meso-zeaxanthin produced continued increases in macular pigmentation into the third year of supplementation, whereas formulas containing only lutein and zeaxanthin plateaued after the first year [1][12].

Factors Affecting Absorption

Take with fat: Lutein and zeaxanthin are fat-soluble carotenoids. Intestinal absorption requires incorporation into mixed micelles formed with dietary fats. One controlled trial found plasma lutein concentrations increased by 207% when lutein esters were consumed with a high-fat spread (36 g fat) compared to only an 88% increase with a low-fat spread (3 g fat) [5][13]. It is generally recommended to take lutein supplements with meals — preferably meals containing fat rather than low-fat meals [1][5].

Type of fat matters: Research using in vitro digestion models and animal studies found that fats rich in saturated fatty acids (e.g., butter, palm oil) resulted in higher lutein and zeaxanthin bioaccessibility than fats rich in monounsaturated or polyunsaturated fatty acids (e.g., olive oil, fish oil). This effect was attributed to smaller mixed micelle sizes with saturated fats, which improve carotenoid solubilization [5][14].

Minerals reduce absorption: Large amounts of divalent mineral ions such as calcium and magnesium can make carotenoids like lutein and zeaxanthin less bioavailable, likely due to a reaction between the carotenoid and the mineral ions [1][15][16]. It is best to take lutein or any carotenoid supplement at a different time of day than a supplement or meal containing large amounts (hundreds of milligrams) of a mineral.

Beta-carotene competition: Beta-carotene from food and supplements may decrease the absorption of lutein, zeaxanthin, and astaxanthin. This interaction is reciprocal — lutein inhibits beta-carotene absorption in a dose-dependent manner [1][5][17][18]. This competitive absorption is one reason the AREDS2 study replaced beta-carotene with lutein and zeaxanthin.

Blood levels peak over time: When using supplements, lutein levels in the blood rise gradually, peaking at approximately 3 months. Research from the National Eye Institute shows that normal adult blood serum levels of lutein double with a daily dose of 2.5 mg, almost triple with 5 mg, and quadruple with 10 mg, suggesting diminishing returns at higher doses [1]. Once supplementation is stopped, blood levels fall over a period of months and return to baseline in about six months [1].

Dose-response for macular pigment: A systematic review and meta-analysis of 46 studies (3,189 participants) confirmed a dose-response relationship for macular pigment optical density (MPOD): daily doses of 5 to less than 20 mg increased MPOD by 0.04 units (95% CI: 0.02-0.07) over 3-12 months, while doses of 20 mg or higher produced a larger increase of 0.11 units (95% CI: 0.06-0.16). Doses below 5 mg showed no significant change in MPOD [5][19].

Dr Brad Stanfield's MicroVitamin includes Lutein 0.25 mg and Lycopene 0.3 mg as part of its 25-ingredient evidence-based formula. While these doses are below the 6-10 mg used in AMD intervention trials, they contribute to baseline carotenoid intake alongside dietary sources.

Supplement Odor

Lutein supplements may have a noticeable odor — described by some as similar to vase water in which flowers have sat too long. This results from the extraction and concentration of lutein esters from marigold flowers. The odor is normal, tends to be stronger in products containing higher amounts (e.g., 20 mg), and is more pronounced with esterified lutein than free-form lutein. Microencapsulated beadlet formulations tend to reduce the odor [1].

Evidence for Benefits

Age-Related Macular Degeneration (AMD)

Age-related macular degeneration is the leading cause of irreversible blindness in developed countries. The macula degenerates with age, resulting in progressive loss of central vision. It is believed that lutein and zeaxanthin protect the macula by scavenging free radicals and absorbing high-energy blue light that would otherwise damage photoreceptors [1][2][3].

Epidemiological Evidence

Population studies consistently show that people who consume the most lutein and zeaxanthin from their diets have lower rates of macular degeneration [1]. One observational study reported a 43% reduced risk of advanced AMD among people consuming approximately 6 mg per day of these carotenoids [2]. The 15-year Blue Mountains Eye Study in Australia found that adults aged 50+ who consumed at least one orange (100 g of edible fruit) per week had 58% reduced odds of developing AMD compared to non-consumers, with benefits attributed to the combination of flavonols and zeaxanthin in oranges [1][20].

AREDS and AREDS2 — Landmark Trials

AREDS (Age-Related Eye Disease Study): This large study evaluated the effect of a combination of supplements on eye health. Although it did not evaluate lutein or zeaxanthin, it established that a combination of zinc, vitamin C (452 mg), vitamin E (400 IU), and beta-carotene (28,640 IU vitamin A), taken as four tablets daily, reduced the risk of progressing to advanced AMD by 25% over 5 years compared to placebo. Zinc alone was also effective [1][21].

The AREDS tablet specifications (per daily dose of four tablets): 28,640 IU vitamin A (from beta-carotene), 452 mg vitamin C, 400 IU vitamin E, 69.6 mg elemental zinc (from zinc oxide), and 1.6 mg copper (from cupric oxide). Copper was included specifically to prevent zinc-induced copper deficiency — not for eye health [1][21].

AREDS2 (2013): This follow-up study tested modifications to the original AREDS formula in 4,203 participants aged 50-85 at moderate to high risk for AMD progression, over 5 years. Researchers evaluated adding 10 mg lutein and 2 mg zeaxanthin, 350 mg DHA and 650 mg EPA, or the combination, to the original AREDS formula. Some groups also tested lower zinc (21.8 mg instead of 69.6 mg) and removal of beta-carotene. Key findings [1][21][22]:

• Adding lutein and zeaxanthin to the original AREDS formulation provided no additional benefit overall. However, in people with very low dietary intake of lutein and zeaxanthin, the addition reduced the risk of disease progression by about 36% compared to the original AREDS formulation.
• Adding omega-3 fatty acids (DHA + EPA from fish oil) provided no additional benefit. A separate large five-year placebo trial also found no benefit from fish oil combined with vitamin D for AMD prevention [1][23].
• Substituting lutein + zeaxanthin for beta-carotene was safe and possibly beneficial — lutein/zeaxanthin was not associated with increased lung cancer risk (unlike beta-carotene), and replacing beta-carotene was associated with a 15% reduction in progression to late AMD [1][24].
• Lower zinc (21.8 mg) was just as effective as the higher dose (69.6 mg), an important finding given the risks of high-dose zinc.
• Removing beta-carotene did not impact efficacy — good news for smokers and former smokers, since beta-carotene increases risk of lung cancer in these groups.

Long-term AREDS2 follow-up: Both the AREDS and AREDS2 formulas were shown to slow advanced (late-stage) dry AMD (geographic atrophy) from expanding into the fovea, reducing progression by approximately 55% over three years. The AREDS2 formula additionally slowed the decline in visual acuity, which the original AREDS formula did not. Neither formula slowed degeneration in more advanced cases already affecting central vision [1][25].

Clinical Trials with Lutein Supplementation

Richer et al. (2004): A double-blind, placebo-controlled study showed that after one year of daily supplementation with 10 mg of lutein (or 10 mg of lutein plus a mixture of antioxidants, vitamins, and minerals), macular pigment increased and vision improved in people with atrophic age-related macular degeneration [1][26].

Bartlett and Eperjesi (2007): A subsequent study using a lower dose of 6 mg lutein daily in fewer participants failed to find benefit for AMD, suggesting that the dose threshold for clinical effect may be closer to 10 mg [1][27].

Obana et al. (2015): A 6-month study in Japan using FloraGLO or XanMax (each capsule containing approximately 10.5 mg lutein and 1 mg zeaxanthin, taken once daily) found no increase in macular pigment density in most participants, except in those with low macular pigment density at baseline [1][28]. This demonstrates a key principle: supplementation appears most beneficial when baseline levels are low.

Korobelnik et al. (2017): A study among 120 men and women (average age 56) in France with a family history of AMD but normal macular pigment density and no other risk factors found that supplementation with lutein (5 mg), zeaxanthin (1 mg), vitamin C (90 mg), vitamin E (15 mg), zinc (7.5 mg), copper (<0.5 mg), resveratrol (0.5 mg), and 33 mg fish oil, taken twice daily for six months, did not increase macular pigment density compared to placebo [1][29]. The message: if macular pigment density is not low, lutein and zeaxanthin may not help.

Akuffo et al. (2015): A 3-year trial compared three formulations in people with early AMD: (1) 20 mg lutein + 0.86 mg zeaxanthin, (2) 10 mg lutein + 2 mg zeaxanthin + 10 mg meso-zeaxanthin, and (3) 3 mg lutein + 2 mg zeaxanthin + 17 mg meso-zeaxanthin. All three formulas significantly increased macular pigmentation during the first year, with no further gain in the second year. During the third year, formulas containing meso-zeaxanthin showed additional pigmentation increases. Vision remained stable (no improvement but no decline) with each formula over the full 3 years, and no progression to advanced AMD occurred [1][12].

Scott et al. (2024) — Pistachios and Macular Pigment: A study of 32 healthy adults (average age 60) with low macular pigment density and low dietary lutein/zeaxanthin intake (<2 mg/day) found that consuming 2 ounces (57 g) of shelled pistachios daily for 12 weeks significantly increased macular pigment density compared to a control group. Benefits appeared after 6 weeks with no additional gain between weeks 6 and 12. Blood lutein levels rose from 18.71 to 27.82 mcg/dL. Each 2-ounce serving of pistachios contained only 1.65 mg of lutein/zeaxanthin — much lower than clinical supplement doses — yet was enough to improve macular pigment in deficient individuals [1][30].

Goji Berries and Macular Pigment

Goji berry (Lycium barbarum) is particularly rich in zeaxanthin, providing about 1 mg per berry. Two studies in China showed that consuming large servings of goji berries daily modestly increased macular pigment optical density (MPOD):

• Li et al. (2022): A 28-gram serving of goji berries (approximately 4 tablespoons, providing about 29 mg zeaxanthin and 0.15 mg lutein) consumed five days per week for three months increased MPOD [1][31].
• Zhang et al. (2022): A 20-gram daily serving of goji berries (providing 20 mg zeaxanthin and 2 mg lutein) consumed for three months also increased MPOD [1][32].

Cataracts

Lutein and zeaxanthin are the primary carotenoids found in the human lens, where they may protect against oxidative damage from ultraviolet light and other reactive oxygen species that contribute to lens opacification [5][34].

Epidemiological evidence: In the Carotenoids in the Age-Related Eye Disease Study (CAREDS), women in the highest quintile of dietary lutein and zeaxanthin intake had a 32% lower prevalence of nuclear cataract compared to those in the lowest quintile (OR 0.68, 95% CI 0.48-0.97) [5][34].

Meta-analyses: One meta-analysis reported pooled relative risks for the highest versus lowest categories of 0.73 (95% CI 0.59-0.87) for lutein and 0.63 (95% CI 0.49-0.77) for zeaxanthin. Combined lutein/zeaxanthin showed a pooled RR of 0.69 (95% CI 0.44-0.94). Associations were stronger for nuclear cataract than for cortical or subcapsular types [5][35].

AREDS2 interventional evidence: Supplementation with 10 mg lutein and 2 mg zeaxanthin daily showed no statistically significant overall effect on progression to cataract surgery (HR 0.96, 95% CI 0.84-1.10, P=0.54) over a median follow-up of 4.7 years. However, among participants with the very lowest baseline dietary intakes, supplementation reduced the number requiring cataract surgery by 32% (HR 0.68, 95% CI 0.48-0.96, P=0.03) [1][5][36].

Dry Eye Disease

A study among 116 men and women with moderate dry eye disease found that one capsule daily containing lutein (20 mg), zeaxanthin isomers (4 mg), curcumin (200 mg curcuminoids), and vitamin D3 (600 IU) for 8 weeks produced a 67% increase in tear production versus only 3% with placebo, and a 57% reduction in severity of dry eye symptoms versus only 13% with placebo. However, supplementation did not increase tear production to within normal ranges or decrease the need for artificial tears. The study was funded by the supplement manufacturers [1][38].

Digital Eye Strain and Screen-Related Symptoms

A study of 35 healthy college-aged men and women (average age 21) given 24 mg daily of a combination of lutein, zeaxanthin, and meso-zeaxanthin (at a ratio of 83%:10%:7%) for six months found, compared to placebo: headaches reduced by 35%, eye strain reduced by 20%, eye fatigue reduced by 30%, and 20% fewer sleep complaints [1][39].

Visual Performance in Healthy Eyes

A 12-month double-blind, placebo-controlled study of 115 healthy young adults supplemented daily with 10 mg lutein plus 2 mg zeaxanthin found significant improvements in photostress recovery time (approximately 9 seconds faster, P=0.013) and chromatic contrast thresholds (approximately 20% improvement, P=0.030), alongside substantial MPOD increases at multiple retinal eccentricities (P<0.0001). Glare disability showed no significant difference (P=0.21) [5][40].

Visual Processing Speed

A placebo-controlled study found that healthy young people taking daily zeaxanthin (20 mg) or zeaxanthin in combination with lutein (26 mg and 8 mg, respectively) showed an average 20% increase in the speed of critical flicker fusion — a measure of visual processing that reflects the ability to discriminate a light source as flickering versus steady. This type of processing typically slows with aging, and faster processing correlates with improved sports performance, driver safety, reading speed, and executive cognitive function [1][42].

Cognitive Function

Lutein and zeaxanthin accumulate in brain tissue in small amounts, and preliminary evidence suggests they may support cognitive function.

Episodic memory (Power et al., 2018): A placebo-controlled study in Ireland among healthy adults with low central macular pigment density found that taking 10 mg lutein, 10 mg meso-zeaxanthin, and 2 mg zeaxanthin daily for 12 months led to improvements in episodic memory [1][43].

Cognitive function in young adults (Stringham et al., 2019): A study among healthy college students found that supplementation with either 13 mg or 27 mg of a lutein/zeaxanthin combination improved overall memory performance, verbal memory, attention, processing speed, and psychomotor speed compared to placebo during the first six months. Blood levels of brain-derived neurotrophic factor (BDNF) increased, and certain inflammatory proteins decreased. However, findings based on the full 12 months were not reported due to "funding constraints" [1][44].

Cognitive function in older adults: A 12-month randomized trial in healthy older adults found that 10 mg lutein plus 2 mg zeaxanthin daily significantly improved complex attention (P<0.02) and cognitive flexibility (P<0.04), with trends toward benefits in executive function and memory, particularly in males [5][45].

Meta-analysis: A meta-analysis of randomized controlled trials found small, non-significant improvements in complex attention (SMD 0.02), executive function (SMD 0.13), and memory (SMD 0.03) with lutein supplementation, suggesting a potential role in preventing age-related cognitive decline rather than producing substantial cognitive enhancement [5][46].

Psychological Stress

A study among healthy young college students with low dietary lutein intake found that supplementing with 13 mg or 27 mg of a lutein/zeaxanthin combination modestly reduced psychological stress scores and cortisol levels. Improvements were statistically significant for the high dose at 6 months and for both doses at 12 months [1][47].

Skin Protection

A 12-week double-blind, placebo-controlled study in healthy adults found that daily oral supplementation with 10 mg lutein and 2 mg zeaxanthin significantly increased the minimal erythemal dose (the UV exposure needed to cause sunburn), improved skin luminance and reduced sallowness, and enhanced skin elasticity and firmness compared to placebo [5][48]. Increased lutein intake has also been associated with a lower risk of colon and breast cancer in observational studies [1].

Cardiovascular Health

A systematic review and meta-analysis reported associations between higher lutein intake and reduced relative risks of coronary heart disease (pooled RR 0.88), stroke (pooled RR 0.82), and metabolic syndrome (pooled RR 0.75) when comparing highest versus lowest intake groups [5][49]. In a 12-week RCT in healthy nonsmokers, 20 mg lutein daily significantly reduced malondialdehyde (a lipid peroxidation marker) and C-reactive protein [5][50]. However, large-scale trials have not consistently demonstrated direct reductions in cardiovascular events.

Saffron as a Complementary Ingredient

Saffron (Crocus sativus) contains antioxidant carotenoids such as crocin and crocetin, and is sometimes added to vision supplements. Several small studies suggest that 20 mg of saffron daily for 3 months to one year can modestly improve retinal sensitivity to light and visual acuity in people with early AMD [1][51][52][53]. A study among 100 men and women (average age 74) in Australia with mild to moderate AMD found that 20 mg of saffron daily for three months modestly improved visual acuity compared to placebo [1][54]. Saffron extract may have a blood-thinning effect, and people taking blood-thinning medication should consult their physician [1].

Retinitis Pigmentosa

A preliminary six-week study using 20 mg of lutein daily in people with retinitis pigmentosa showed improvements in their vision [1][37]. This evidence is preliminary and requires replication.

Presbyopia

A study in Japan among 50 adults (average age 53) found that supplementation with 10 mg lutein, 4 mg astaxanthin, 20 mg bilberry extract, 26.5 mg black soybean hull extract, and 50 mg DHA daily for 4 weeks did not improve near-point accommodation compared to placebo [1][41]. Supplements marketed for presbyopia generally contain ingredients studied for other aspects of eye health but not specifically evaluated for presbyopia.

Recommended Dosing

No Established RDA

There is no government-recommended daily intake (RDA) for lutein or zeaxanthin. They are classified as non-essential carotenoids without established dietary reference intakes [1][2][6].

Population-Level Targets

Based on epidemiological studies, consuming approximately 6 mg per day of combined lutein and zeaxanthin from foods is associated with reduced risk of both AMD and cataract formation [1][6]. The average American adult consumes only 1-4 mg per day [1][2].

Clinical Supplementation Doses

For age-related macular degeneration (intermediate or advanced in one eye): The AREDS2 formula — 10 mg lutein + 2 mg zeaxanthin daily — is the reference standard recommended by the American Academy of Ophthalmology. This should be taken as part of the full AREDS2 formula: vitamin C 500 mg, vitamin E 400 IU, zinc 25 mg, copper 2 mg, lutein 10 mg, zeaxanthin 2 mg [1][2][21][22][57].

For increasing macular pigment optical density: Doses of 5-20 mg per day consistently increase MPOD. Meta-analytic data: below 5 mg/day = no significant effect; 5-20 mg/day = 0.04 unit increase; 20+ mg/day = 0.11 unit increase [5][19].

For general eye health and prevention: 6-10 mg per day of lutein from dietary sources or supplements, with 2 mg zeaxanthin, is a reasonable target for most adults [1][6].

For retinitis pigmentosa: 20 mg per day showed benefit in a preliminary six-week study [1][37].

For digital eye strain: 24 mg per day of lutein + zeaxanthin + meso-zeaxanthin (83:10:7 ratio) showed benefit over six months [1][39].

Lower Zinc is Sufficient

A key finding from AREDS2 is that 21.8 mg of elemental zinc was just as effective as the original 69.6 mg dose for slowing AMD progression [1][21]. This is clinically important because the higher dose exceeds the Tolerable Upper Intake Level of 40 mg/day and can cause copper deficiency.

Blood Level Kinetics

Blood lutein levels rise gradually with supplementation, peaking at approximately 3 months. Dose-response data from the National Eye Institute: 2.5 mg/day doubles serum lutein; 5 mg/day nearly triples it; 10 mg/day quadruples it — demonstrating diminishing returns at higher doses [1].

Practical Tips

• Take lutein with a meal containing fat for optimal absorption [1][5][13]
• Separate from high-dose mineral supplements by several hours [1][15][16]
• If you already get a high amount of lutein from your diet, supplementation may not provide additional benefit [1]
• Macular pigment benefits may plateau after 6-12 months for lutein/zeaxanthin alone, though meso-zeaxanthin formulas may continue building for up to 3 years [1][12]

Safety and Side Effects

General Safety

Lutein supplements are generally recognized as safe (GRAS) by the U.S. FDA [5][58][59]. Clinical trials including the large-scale AREDS2 have demonstrated that lutein supplementation is well-tolerated with no serious adverse events reported over long-term follow-up [5][60]. Doses of 10 mg/day appear safe based on multiple trials; a six-month study at 20 mg/day also showed no safety problems [1][37]. The EFSA concluded that synthetic zeaxanthin is safe at daily doses up to 53 mg [1][11].

Carotenodermia

The most commonly reported adverse effect is carotenodermia — a benign, harmless, and reversible yellow-orange discoloration of the skin that may occur with very high or prolonged intake, typically at doses exceeding 15-20 mg daily over months. This condition resolves upon reduction or cessation of intake [5][61][62].

Lung Cancer Risk Concern

A retrospective study found that long-term supplementation with lutein, as well as vitamin A (from beta-carotene or retinol), was associated with an increased risk of lung cancer [1][63]. Long-term use should not be recommended for lung cancer prevention, particularly among smokers. Importantly, the AREDS2 trial found that replacing beta-carotene with lutein/zeaxanthin eliminated the increased lung cancer risk associated with beta-carotene [1][24].

High-Dose Zinc Risks in Vision Formulas

Some AREDS-based vision formulas contain zinc doses exceeding the 40 mg/day Tolerable Upper Intake Level. Excess zinc inhibits copper absorption, which can cause changes in blood cell counts, immune suppression, anemia, heart problems, balance/walking difficulty, and cognitive changes [1][64].

Case reports include an 81-year-old woman who took a formula containing 80 mg zinc and 2 mg copper daily for several years and developed copper deficiency with anemia and low blood counts, resolving after stopping the supplement [1][64]. A similar case occurred in a 74-year-old woman on the same product [1][65]. The AREDS2 finding that 21.8 mg zinc is as effective as 69.6 mg makes high-dose formulations unnecessary [1][21].

Drug Interactions

Lutein supplements are not known to have major drug interactions. Drug interaction databases report no severe, serious, moderate, or mild interactions with other medications [5][66][67].

Known Interactions

Beta-carotene: Lutein and beta-carotene compete for intestinal absorption, potentially reducing the bioavailability of one or both when taken together. This is a dose-dependent reciprocal interaction [1][5][17][18].

Olestra: The fat substitute olestra may reduce absorption of lutein and zeaxanthin [1].

Omega-3 fatty acids: No known interactions exist between lutein and fish oil supplements. Clinical studies commonly combine them without reported adverse effects [5][68].

Mineral supplements: Large doses of divalent mineral ions (calcium, magnesium) may reduce carotenoid bioavailability when taken simultaneously. Separation by a few hours is recommended [1][15][16].

Saffron (in combination products): Saffron extract may have a blood-thinning effect. People taking anticoagulant medications should consult their physician before taking saffron-containing vision supplements [1].

Pregnancy and Breastfeeding

Lutein is generally recognized as safe when consumed in food amounts and naturally occurs in breast milk. However, reliable information is insufficient to confirm the safety of supplemental doses during pregnancy or breastfeeding. Users should consult a healthcare provider [5][6].

Dietary Sources

There is no government-established RDA for lutein or zeaxanthin. Population studies associate approximately 6 mg per day of combined intake with reduced risk of AMD and cataracts. The average American adult consumes only 1-4 mg per day [1][2][6]. As little as a half-cup of cooked kale, Swiss chard, spinach, or collard greens provides 6 mg or more [1].

Food	Serving	Lutein + Zeaxanthin (mg)
Kale (raw)	100 g	~6.3
Spinach (cooked)	1/2 cup	~6+
Collard greens (cooked)	1/2 cup	~6+
Swiss chard (cooked)	1/2 cup	~6+
Turnip greens	1/2 cup	High
Corn	1/2 cup	Moderate
Peas (green)	1/2 cup	Moderate
Broccoli	1/2 cup	Moderate
Romaine lettuce	1 cup	Moderate
Zucchini	1/2 cup	Moderate
Kiwi fruit	1 medium	Moderate
Pistachios (shelled)	2 oz (57 g)	~1.65
Egg yolk (enriched)	1 egg	Varies

Sources: USDA National Nutrient Database, ConsumerLab [1][2].

Zeaxanthin-Rich Sources

Most foods contain more lutein than zeaxanthin, but peppers, oranges, and orange juice typically contain more zeaxanthin than lutein [1]. Goji berries are exceptionally rich in zeaxanthin, providing approximately 1 mg per berry [1][31][32].

Practical Recommendations

• Consume at least one serving of dark leafy greens daily (kale, spinach, collard greens)
• Include at least one orange per week — the Blue Mountains study found this associated with 58% reduced odds of AMD [1][20]
• Eat fish at least once a week, as this is also associated with reduced AMD risk [1]
• Add healthy fats when eating carotenoid-rich vegetables to enhance absorption
• If dietary intake is consistently low (<2 mg/day), supplementation may be warranted [1][6]

References

1. ConsumerLab. "Lutein and Zeaxanthin Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/lutein-zeaxanthin-supplements-review/lutein/

2. Grokipedia. "Lutein supplements." https://grokipedia.com/page/Lutein_supplements

3. Bernstein PS, Li B, Vachali PP, et al. "Lutein, Zeaxanthin, and Meso-Zeaxanthin." Prog Retin Eye Res. 2016;50:34-66. https://doi.org/10.1016/j.preteyeres.2015.10.003

4. Li B, Ahmed F, Bernstein PS. "Studies on the singlet oxygen scavenging mechanism of human macular pigment." Arch Biochem Biophys. 2010;504(1):56-60. https://doi.org/10.1016/j.abb.2010.07.024

5. Grokipedia. "Lutein supplements — Forms and Bioavailability." https://grokipedia.com/page/Lutein_supplements

6. Abdel-Aal EM, et al. "Dietary Sources of Lutein and Zeaxanthin Carotenoids." Nutrients. 2013;5(4):1169-1185. https://doi.org/10.3390/nu5041169

7. Johnson EJ. "Role of lutein and zeaxanthin in visual and cognitive function." Nutr Rev. 2014;72(9):605-612. https://doi.org/10.1111/nure.12133

8. Olmedilla-Alonso B, et al. "Bioavailability of Lutein from Marigold Flowers (Free vs. Ester Forms)." Nutrients. 2024. https://doi.org/10.3390/nu16010127

9. Bettler J, et al. "Serum lutein concentrations in healthy term infants." Eur J Nutr. 2010;49(1):45-51. https://doi.org/10.1007/s00394-009-0047-5

10. Evans M, et al. "Effects of formulation on the bioavailability of lutein and zeaxanthin." Eur J Nutr. 2012. https://doi.org/10.1007/s00394-012-0402-5

11. European Food Safety Authority (EFSA). "Scientific opinion on the safety of synthetic zeaxanthin." EFSA Journal. 2012. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2012.2891

12. Akuffo KO, et al. "Sustained supplementation with differing carotenoid formulations in early AMD." Eye. 2015;29(7):902-912. https://doi.org/10.1038/eye.2015.64

13. Roodenburg AJ, et al. "Amount of fat in the diet affects bioavailability of lutein esters." Am J Clin Nutr. 2000;71(5):1187-1193. https://doi.org/10.1093/ajcn/71.5.1187

14. Gleize B, et al. "Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability." Br J Nutr. 2013;110(1):1-10. https://doi.org/10.1017/S0007114512004813

15. Corte-Real J, Bohn T. "Interaction of divalent minerals with carotenoids." Food Chem. 2016;197:546-554. https://doi.org/10.1016/j.foodchem.2015.10.085

16. Biehler E, et al. "Divalent minerals decrease micellarization and uptake of carotenoids." J Nutr. 2011;141(10):1769-1776. https://doi.org/10.3945/jn.111.143388

17. van den Berg H, van Vliet T. "Effect of simultaneous oral doses of beta-carotene with lutein." Am J Clin Nutr. 1998;68(1):82-89. https://doi.org/10.1093/ajcn/68.1.82

18. Kostic D, et al. "Intestinal absorption and interactions between lutein and beta-carotene." Am J Clin Nutr. 1995;62(3):604-610. https://doi.org/10.1093/ajcn/62.3.604

19. Ma L, et al. "Effect of lutein/zeaxanthin intake on human MPOD: a systematic review and meta-analysis." Br J Nutr. 2012;108(3):349-356. https://doi.org/10.1017/S0007114511006150

20. Gopinath B, et al. "Dietary flavonoids and AMD." Am J Clin Nutr. 2018;108(1):159-165. https://doi.org/10.1093/ajcn/nqy046

21. Age-Related Eye Disease Study Research Group. "AREDS report no. 8." Arch Ophthalmol. 2001;119(10):1417-1436. https://doi.org/10.1001/archopht.119.10.1417

22. AREDS2 Research Group. "AREDS2 randomized clinical trial." JAMA. 2013;309(19):2005-2015. https://doi.org/10.1001/jama.2013.4997

23. Christen WG, et al. "Effect of Vitamin D and omega-3 on AMD Risk." JAMA Ophthalmol. 2020;138(12):1280-1289. https://doi.org/10.1001/jamaophthalmol.2020.4409

24. Chew EY, et al. "Long-Term Outcomes of Adding Lutein/Zeaxanthin to AREDS." JAMA Ophthalmol. 2022;140(4):347-354. https://doi.org/10.1001/jamaophthalmol.2022.0029

25. Keenan TDL, et al. "AREDS and AREDS2 Formulas Slow Geographic Atrophy Progression." Ophthalmology. 2024. https://doi.org/10.1016/j.ophtha.2023.12.024

26. Richer S, et al. "Veterans LAST study." Optometry. 2004;75(4):216-230. https://doi.org/10.1016/S1529-1839(04)70049-4

27. Bartlett HE, Eperjesi F. "Lutein supplementation in AMD." Eur J Clin Nutr. 2007;61(9):1121-1127. https://doi.org/10.1038/sj.ejcn.1602626

28. Obana A, et al. "Changes in MPOD with lutein supplements." PLoS One. 2015;10(10):e0139257. https://doi.org/10.1371/journal.pone.0139257

29. Korobelnik JF, et al. "Effect of Dietary Supplementation on Macular Pigment." JAMA Ophthalmol. 2017;135(11):1259-1266. https://doi.org/10.1001/jamaophthalmol.2017.3398

30. Scott TM, et al. "Pistachio Consumption Increases MPOD." J Nutr. 2024. https://doi.org/10.1016/j.tjnut.2024.01.010

31. Li X, et al. "Goji Berry Intake Increases MPOD." Nutrients. 2022;14(20):4409. https://doi.org/10.3390/nu14204409

32. Zhang J, et al. "Lycium barbarum and macular pigment." Graefes Arch Clin Exp Ophthalmol. 2022. https://doi.org/10.1007/s00417-022-05633-4

33. American Academy of Ophthalmology Task Force on Genetic Testing. "Recommendations on genetic testing for AMD." 2014.

34. Moeller SM, et al. "Nuclear Cataract and Lutein/Zeaxanthin (CAREDS)." Arch Ophthalmol. 2008;126(3):354-364. https://doi.org/10.1001/archopht.126.3.354

35. Liu XH, et al. "Lutein/zeaxanthin and cataract risk: a meta-analysis." Nutrients. 2014;6(1):452-465. https://doi.org/10.3390/nu6010452

36. Chew EY, et al. "Lutein/zeaxanthin for age-related cataract: AREDS2 report no. 4." JAMA Ophthalmol. 2013;131(7):843-850. https://doi.org/10.1001/jamaophthalmol.2013.4412

37. Bahrami H, et al. "Lutein supplementation in retinitis pigmentosa." BMC Ophthalmol. 2006;6:23. https://doi.org/10.1186/1471-2415-6-23

38. Gioia C, et al. "Lutein, zeaxanthin, curcumin, vitamin D3 for dry eye." Front Ophthalmol. 2024. https://doi.org/10.3389/fopht.2024.1365800

39. Stringham JM, et al. "Macular Carotenoid Supplementation and Photostress Recovery." Foods. 2017;6(7):56. https://doi.org/10.3390/foods6070056

40. Hammond BR Jr, et al. "Lutein/Zeaxanthin and Photostress Recovery." Invest Ophthalmol Vis Sci. 2014;55(12):8583-8589. https://doi.org/10.1167/iovs.14-15573

41. Kono S, et al. "Supplement for presbyopia." Curr Med Chem. 2014.

42. Bovier ER, et al. "Lutein/zeaxanthin and neural processing speed." Arch Biochem Biophys. 2015;572:54-57. https://doi.org/10.1016/j.abb.2014.11.012

43. Power R, et al. "Retinal Carotenoids Enhance Memory." J Alzheimers Dis. 2018;61(3):947-961. https://doi.org/10.3233/JAD-170713

44. Stringham NT, et al. "Macular carotenoids, stress, and cognition." Nutr Neurosci. 2018;21(4):286-296. https://doi.org/10.1080/1028415X.2017.1286445. Also: Stringham JM, et al. Physiol Behav. 2019;200:11-21. https://doi.org/10.1016/j.physbeh.2018.05.026

45. Hammond BR Jr, et al. "Lutein/Zeaxanthin and Cognitive Function in Older Adults." Front Aging Neurosci. 2017;9:254. https://doi.org/10.3389/fnagi.2017.00254

46. Yagi A, et al. "Lutein and Cognitive Function: A Meta-Analysis." Nutrients. 2023. https://doi.org/10.3390/nu15061480

47. Stringham NT, et al. "Macular Xanthophyll Supplementation, BDNF, and Cognition." Physiol Behav. 2019;211:112650. https://doi.org/10.1016/j.physbeh.2019.112650

48. Juturu V, et al. "Skin tone and lightening with lutein/zeaxanthin." Clin Cosmet Investig Dermatol. 2016;9:325-332. https://doi.org/10.2147/CCID.S115519

49. Leermakers ET, et al. "Lutein and cardiometabolic health." Am J Clin Nutr. 2016;103(2):481-494. https://doi.org/10.3945/ajcn.115.120931

50. Xu XR, et al. "Lutein Reduces Lipid Peroxidation and CRP." Atherosclerosis. 2013;227(2):380-385. https://doi.org/10.1016/j.atherosclerosis.2013.01.025

51. Falsini B, et al. "Saffron and retinal sensitivity in AMD." Invest Ophthalmol Vis Sci. 2010;51(12):6118-6124. https://doi.org/10.1167/iovs.09-4995

52. Piccardi M, et al. "Saffron in early AMD." Evid Based Complement Alternat Med. 2012;2012:429124. https://doi.org/10.1155/2012/429124

53. Marangoni D, et al. "Saffron and risk genotypes in AMD." J Transl Med. 2013;11:228. https://doi.org/10.1186/1479-5876-11-228

54. Broadhead GK, et al. "Saffron for AMD." Graefes Arch Clin Exp Ophthalmol. 2019;257(1):31-40. https://doi.org/10.1007/s00417-018-4163-x

55. Rashid NA, et al. Pharmaceuticals (Basel). 2022;15(8):973. https://doi.org/10.3390/ph15080973

56. Inokuchi Y, et al. Evid Based Complement Alternat Med. 2006;3(1):71-77. https://doi.org/10.1093/ecam/nek005

57. American Academy of Ophthalmology. "Vitamins for AMD." https://www.aao.org/eye-health/tips-prevention/vitamins-amd

58. U.S. FDA. "GRAS Notice No. GRN 000140 — Lutein." https://www.fda.gov/food/gras-notice-inventory/agency-response-letter-gras-notice-no-grn-000140

59. U.S. FDA. "GRAS Notices — Lutein Esters." https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory

60. AREDS2 Research Group. "Long-term outcomes of AREDS2 supplementation." JAMA Ophthalmol. 2022.

61. Leo MA, Lieber CS. "Carotenodermia." https://pubmed.ncbi.nlm.nih.gov/10586992/

62. Poison Control. "Safety and benefits of lutein." https://www.poison.org/articles/safety-benefits-of-lutein

63. Satia JA, et al. "Long-term use of supplements and lung cancer risk." Am J Epidemiol. 2009;169(7):815-828. https://doi.org/10.1093/aje/kwn409

64. Wahab A, et al. "Zinc-induced copper deficiency from macular degeneration supplements." J Community Hosp Intern Med Perspect. 2021;11(5):689-691. https://doi.org/10.1080/20009666.2021.1957496

65. Miatech JL, et al. "Copper deficiency from vision supplement." Cureus. 2024. https://doi.org/10.7759/cureus.54812

66. RxList. "Lutein: Side Effects, Uses, Dosage, Interactions." https://www.rxlist.com/lutein/supplements.htm

67. Drugs.com. "Lutein/Zeaxanthin Interactions." https://www.drugs.com/drug-interactions/lutein-zeaxanthin.html

68. Drugs.com. "Fish Oil and Lutein Interactions." https://www.drugs.com/drug-interactions/fish-oil-with-lutein.html